Math Over Myth: Positive Technical Divergences in the Psychedelic Sector
Business, Stock ReportsMath over Myth is your weekly guide to stocks and ETFs in the psychedelic sector, this week focusing on the ETF PSIL
Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop
Business, Stock ReportsMath over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
Business, Stock ReportsMath over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more
Math Over Myth: Weekly Psychedelic Stocks News Roundup
Business, Stock ReportsGet the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive
Math Over Myth: September Psychedelic Stock News Roundup
Business, Stock ReportsTrack the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup
Math Over Myth: MindMed’s Self Destructive Stock Mission
Business, Stock ReportsPsychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors
Math Over Myth: Psychedelic Stock HAVN Life Collapses
Business, Stock ReportsThe psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Math Over Myth: Spotlight on MindMed
Business, Stock ReportsIn the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers
Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
Business, Stock ReportsIf you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
Business, Investing, Stock ReportsCathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?